Clinical Trials Browser

Phase 2 × Radiation Injuries × Olanzapine × Clear all

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting